Drugs & Therapy Perspectives

, Volume 24, Issue 10, pp 5–8 | Cite as

Oxycodone/paracetamol: a guide to its use in the treatment of moderate to severe musculoskeletal pain

Drug and Profile Reports


  1. 1.
    Barkin Rl. Acetaminophen, aspirin, or ibuprofen in combination analgesic products. Am J Therapeut 2001; 8(6): 433–42CrossRefGoogle Scholar
  2. 2.
    Auret K, Schug SA. Underutilisation of opioids in elderly patients with chronic pain: approaches to correcting the problem. Drugs Aging 2005; 22(8): 641–54PubMedCrossRefGoogle Scholar
  3. 3.
    Nikolaus T, Zeyfang A. Pharmacological treatments for persistent non-malignant pain in older persons. Drugs Aging 2004; 21(1): 19–41PubMedCrossRefGoogle Scholar
  4. 4.
    Devulder J, Richarz U, Nataraja SH. Impact of long-term use of opioids on quality of life in patient with chronic, non-malignant pain. Curr Med Res Opin 2005; 21(10): 1555–69PubMedCrossRefGoogle Scholar
  5. 5.
    Bannwarth B. Risk-benefit assessment of opioids in chronic non-cancer pain. Drug Saf 1999 Oct; 21(4): 283–96PubMedCrossRefGoogle Scholar
  6. 6.
    World Health Organization. Cancer pain relief with a guide to opioid availability. 2nd ed. Geneva: WHO, 1996Google Scholar
  7. 7.
    Depalgos (oxycodone plus paracetamol): summary of product characteristics [in Italian]. L. Molteni s& C. dei Fratelli Alitti Società di Esercizio S.p.A.; Florence, Italy, 2006Google Scholar
  8. 8.
    Institute for Clinical Systems Improvement. Health care guideline: assessment and management of chronic pain [online]. Available from URL: [Accessed 2008 Aug 16]
  9. 9.
    Institute for Clinical Systems Improvement. Health care guideline: assessment and management of acute pain [online]. Available from URL: [Accessed 2008 Aug 16]
  10. 10.
    Sweetman S, editor. Martindale: the complete drug reference. 35th ed. London: Pharmaceutical Press, 2007Google Scholar
  11. 11.
    WoltersKluwer Health Inc. Facts & comparisons 4.0 [online]. Available from URL: [Accessed 2008 Aug 15]
  12. 12.
    Riley J, Eisenberg E, Müller-Schefe G, et al. Oxycodone: a review of its use in the management of pain. Curr Med Res Opin 2008; 24(1): 175–92PubMedCrossRefGoogle Scholar
  13. 13.
    Kalso E, Allan L, Dellemijn PL, et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 2003; 7(5): 381–6PubMedCrossRefGoogle Scholar
  14. 14.
    Gammaitoni AR, Galer BS, Lacouture P, et al. Effectiveness and safety of new oxycodone/acetaminophen formulations with reduced acetaminophen for the treatment of low back pain. Pain Med 2003 Mar; 4(1): 20–30CrossRefGoogle Scholar
  15. 15.
    Nicholson B. Responsible prescribing of opioids for the management of chronic pain. Drugs 2003; 63(1): 17–31PubMedCrossRefGoogle Scholar
  16. 16.
    Jamison RN, Schein JR, Vallow S, et al. Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage 2003 Oct; 26(4): 913–21PubMedCrossRefGoogle Scholar
  17. 17.
    Verster JC, Veldhuijzen DS, Volkerts ER. Effects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood. Clin J Pain 2006 Jun; 22(5): 499–504PubMedCrossRefGoogle Scholar
  18. 18.
    Schug SA, Zech D, Grond S. Adverse effects of systemic opioid analgesics. Drug Saf 1992; 7(3): 200–13PubMedCrossRefGoogle Scholar
  19. 19.
    Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain 2002; 18(4 Suppl.): S28–38PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2008

Personalised recommendations